Skip to main content

Advertisement

Log in

Mastoid obliteration with hydroxyapatite vs. bone pâté in mastoidectomy surgery performed on patients with cholesteatoma and chronic suppurative otitis media: a retrospective analysis

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

To compare the efficacy and safety of hydroxyapatite vs. bone pâté as obliteration material in mastoidectomy surgery for patients with chronic suppurative otitis media and cholesteatoma.

Methods

This is a retrospective, multi-center, cohort study. All patients were followed up with micro-otoscopy, audiometry, and, if indicated, MRI with diffusion-weighted imaging. The following outcome parameters were analyzed: procedure safety (wound infections and complications), cholesteatoma recidivism rates (residual/recurrent), control of infection (Merchant’s scale), and hearing results (pure-tone averages at 500/1000/2000/4000 Hz).

Results

Eighty-three cases were included: 45 obliterated with hydroxyapatite and 38 with bone pâté, with a mean follow-up time of, respectively, 25 and 24 months. Wound infections were only detected in the bone pâté group (4.8%) and successfully treated with oral or intravenous antibiotics and surgical drainage (p = 0.026). No other major surgical complications were observed in both groups. Cholesteatoma recidivism was observed in 15% using hydroxyapatite and 12% using bone pâté (p = 0.471). Complete control of infection (Merchant 0) was achieved in 76.2% using bone pâté and 86.8% using hydroxyapatite at 12 months postoperatively (p = 0.223). All patients showed good postoperative healing without complete failure to manage infection (Merchant 3). Pre- and postoperative audiometry showed significant improvement in hearing results in both groups. No significant difference between the obliteration materials was observed.

Conclusions

Evaluation of mastoid obliteration reveals that hydroxyapatite and bone pâté are safe and effective obliteration materials, with high success rates in achieving a dry ear, low recidivism rates, and good hearing outcome, respecting the short-term limitation. In addition, our study shows that hydroxyapatite results in fewer postoperative wound infections compared to bone pâté.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hellingman CA, Geerse S, de Wolf MJ, Ebbens FA, van Spronsen E (2019) Canal wall up surgery with mastoid and epitympanic obliteration in acquired cholesteatoma. Laryngoscope 129:981–985. https://doi.org/10.1002/lary.27588

    Article  PubMed  Google Scholar 

  2. Karamert R, Eravci FC, Cebeci S, Düzlü M, Zorlu ME, Yasar NG et al (2019) Canal wall down versus canal wall up surgeries in the treatment of middle ear cholesteatoma. Turk Jl Med Sci 49:1426–1432. https://doi.org/10.3906/sag-1904-109

    Article  Google Scholar 

  3. Kuo CL, Shiao AS, Yung M, Sakagami M, Sudhoff H, Wang CH et al (2015) Updates and knowledge gaps in cholesteatoma research. Biomed Res Int 2015:1–17. https://doi.org/10.1155/2015/854024

    Article  CAS  Google Scholar 

  4. Dornhoffer JL, Friedman AB, Gluth MB (2013) Management of acquired cholesteatoma in the pediatric population. Curr Opin Otolaryngol Head Neck Surg 21:440–445. https://doi.org/10.1097/MOO.0b013e32836464bd

    Article  PubMed  Google Scholar 

  5. Kerckhoffs KG, Kommer MB, van Strien TH, Visscher SJ, Bruijnzeel H, Smit AL et al (2016) The disease recurrence rate after the canal wall up or canal wall down technique in adults. Laryngoscope 126:980–987. https://doi.org/10.1002/lary.25591

    Article  PubMed  Google Scholar 

  6. Komori M, Morita Y, Tono T, Matsuda K, Yamamoto Y, Sakagami M et al (2021) Nationwide survey of middle ear cholesteatoma surgery cases in Japan: results from the Japan Otological society registry using the JOS staging and classification system. Auris Nasus Larynx 48:555–564. https://doi.org/10.1016/j.anl.2020.09.011

    Article  PubMed  Google Scholar 

  7. Gantz BJ, Wilkinson EP, Hansen MR (2005) Canal wall reconstruction tympanomastoidectomy with mastoid obliteration. Laryngoscope 115:1734–1740. https://doi.org/10.1097/01.MLG.0000187572.99335.cc

    Article  PubMed  Google Scholar 

  8. Walker PC, Mowry SE, Hansen MR, Gantz BJ (2014) Long-term results of canal wall reconstruction tympanomastoidectomy. Otol Neurotol 35:954–960. https://doi.org/10.1097/MAO.0b013e3182a446da

    Article  PubMed  Google Scholar 

  9. Yamamoto Y, Takahashi K, Morita Y, Ohshima S, Takahashi S (2014) Long-term follow-up results of canal wall down tympanoplasty with mastoid obliteration using the bone pate plate for canal wall reconstruction in cholesteatoma surgery. Otol Neurotol 35:961–965. https://doi.org/10.1097/MAO.0000000000000414

    Article  PubMed  Google Scholar 

  10. Patil S, Trinidade A, Wong B, Yung MW (2021) Secondary obliteration surgery for troublesome mastoid cavities: a prospective series of 228 pediatric and adult cases. Otol Neurotol 42:881–886. https://doi.org/10.1097/MAO.0000000000003114

    Article  Google Scholar 

  11. Roux A, Bakhos D, Lescanne E, Cottier JP, Robier A (2015) Canal wall reconstruction in cholesteatoma surgeries: rate of residual. Eur Arch Otorhinolaryngol 272:2791–2797. https://doi.org/10.1007/s00405-014-3280-3

    Article  CAS  PubMed  Google Scholar 

  12. Edfeldt L, Strömbäck K, Kinnefors A, Rask-Andersen H (2012) Surgical treatment of adult cholesteatoma: long-term follow-up using total reconstruction procedure without staging. Acta Otolaryngol 133:28–34. https://doi.org/10.3109/00016489.2012.707333

    Article  PubMed  Google Scholar 

  13. van Dinther JJ, Vercruysse J, Camp S, De Foer B, Casselman J, Somers T et al (2015) The bony obliteration tympanoplasty in pediatric cholesteatoma: Long-term safety and hygienic results. Otol Neurotol 36:1504–1509. https://doi.org/10.1097/MAO.0000000000000851

    Article  PubMed  Google Scholar 

  14. van Dinther JJS, Coopman R, Vercruysse JP, Somers T, Zarowski A, Vanspauwen R et al (2018) The bony obliteration tympanoplasty in pediatric cholesteatoma: long-term hearing results. Otol Neurotol 39:715–723. https://doi.org/10.1097/MAO.0000000000001846

    Article  PubMed  Google Scholar 

  15. van der Toom HFE, van der Schroeff MP, Janssen JMH, Westzaan AM, Pauw RJ (2020) A retrospective analysis and comparison of the STAM and STAMCO classification and EAONO/JOS cholesteatoma staging system in predicting surgical treatment outcomes of middle ear cholesteatoma. Otol Neurotol 41:468–474. https://doi.org/10.1097/MAO.0000000000002549

    Article  Google Scholar 

  16. van der Toom HFE, van der Schroeff MP, Metselaar M, van Linge A, Vroegop JL, Pauw RJ (2021) Treatment outcome of the bony obliteration tympanoplasty versus nonobliterative techniques in cholesteatoma surgery: a retrospective analysis. Otol Neurotol 42:1366–1374. https://doi.org/10.1097/MAO.0000000000003246

    Article  PubMed  Google Scholar 

  17. van der Toom HFE, van der Schroeff MP, Pauw RJ (2018) Single-stage mastoid obliteration in cholesteatoma surgery and recurrent and residual disease rates: a systematic review. JAMA Otolaryngol Head Neck Surg 144:440–446. https://doi.org/10.1001/jamaoto.2017.3401

    Article  PubMed  Google Scholar 

  18. Tomlin J, Chang D, McCutcheon B, Harris J (2013) Surgical technique and recurrence in cholesteatoma: a meta-analysis. Audiol Neurootol 18:135–142. https://doi.org/10.1159/000346140

    Article  PubMed  Google Scholar 

  19. Leatherman BD, Dornhoffer JL (2004) The use of demineralized bone matrix for mastoid cavity obliteration. Otol Neurotol 25:22–26

    Article  PubMed  Google Scholar 

  20. Alves RD, Cabral Junior F, Fonseca ACDO, Bento RF (2016) Mastoid obliteration with autologous bone in mastoidectomy canal wall down surgery: a literature overview. Intl Arch Otorhinolaryngol 20(1):76–83. https://doi.org/10.1055/s-0035-1563382

    Article  Google Scholar 

  21. Skoulakis C, Koltsidopoulos P, Iyer A, Kontorinis G (2019) Mastoid obliteration with synthetic materials: a review of the literature. J Int Adv Otol 15:400–404. https://doi.org/10.5152/iao.2019.7038

    Article  PubMed  PubMed Central  Google Scholar 

  22. Yung M (1996) The use of hydroxyapatite granules in mastoid obliteration. Clin Otolaryngol 21(6):480–484. https://doi.org/10.1111/j.1365-2273.1996.tb01094.x

    Article  CAS  PubMed  Google Scholar 

  23. Mahendran S, Yung M (2004) Mastoid obliteration with hydroxyapatite cement: the Ipswich experience. Otol Neurotol 25:19–21

    Article  CAS  PubMed  Google Scholar 

  24. Munjal M, Passey J, Agarwal A, Meher R (2004) Hydroxyapatite granules for mastoid cavity obliteration: a study of 25 cases. Internet J Otorhinolaryngol 3:1–4

    Google Scholar 

  25. Shree NR, Ravikumar A, Sarvanam PK (2021) Mastoid obliteration: a comparison of two techniques. Indian J Otolaryngol Head Neck Surg. https://doi.org/10.1007/s12070-021-02472-5

    Article  PubMed  Google Scholar 

  26. Yung M, Bennett A (2013) Use of mastoid obliteration techniques in cholesteatoma. Curr Opin Otolaryngol Head Neck Surg 21:455–460. https://doi.org/10.1097/MOO.0b013e3283646521

    Article  PubMed  Google Scholar 

  27. George JS, Kakkar V, Gupta V, Dheeraj S, Bhukar S, Verma M (2021) Mastoid cavity obliteration with hydroxyapatite granules: A prospective study. Saudi J Otorhinolaryngol Head Neck Surg 23:6–10. https://doi.org/10.4103/SJOH.SJOH_22_20

    Article  Google Scholar 

  28. Weiss NM, Stecher S, Bächinger D, Schuldt T, Langner S, Zonnur S et al (2020) Open mastoid cavity obliteration with a high-porosity hydroxyapatite ceramic leads to high rate of revision surgery and insufficient cavity obliteration. Otol Neurotol 41:55–63. https://doi.org/10.1097/MAO.0000000000002413

    Article  Google Scholar 

  29. de Veij Mestdagh PD, Colnot DR, Borggreven PA, Orelio CC, Quak JJ (2017) Mastoid obliteration with S53P4 bioactive glass in cholesteatoma surgery. Acta Otolaryngol 137:690–694. https://doi.org/10.1080/00016489.2017.1279346

    Article  CAS  PubMed  Google Scholar 

  30. Vos J, de Veij Mestdagh PD, Colnot DR, Borggreven PA, Orelio CCC, Quak JJ (2017) Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients. Eur Arch Otorhinolaryngol 274:4121–4126. https://doi.org/10.1007/s00405-017-4757-7

    Article  PubMed  Google Scholar 

  31. Merchant SN, Wang P, Jang C, Glynn RJ, Rauch SD, McKenna MJ et al (1997) Efficacy of tympanomastoid surgery for control of infection in active chronic otitis media. Laryngoscope 107:872–877. https://doi.org/10.1097/00005537-199707000-00007

    Article  CAS  PubMed  Google Scholar 

  32. Merkus P, Fleur A, Stam M, Tan FM, Pauw RJ (2017) Implementation of the “EAONO/JOS definitions and classification of middle ear cholesteatoma”—from STAM to STAMCO. J Int Adv Otol 13:272–274. https://doi.org/10.5152/iao.2017.4049

    Article  PubMed  Google Scholar 

  33. Ghiasi S (2015) Mastoid cavity obliteration with combined palva flap and bone pâté. Iran J Otorhinolaryngol 27:23–28. https://doi.org/10.1136/bcr-2020-241160

    Article  PubMed  PubMed Central  Google Scholar 

  34. Geerse S, Ebbens FA, De Wolf MJF, van Spronsen E (2017) Successful obliteration of troublesome and chronically draining cavities. J Laryngol Otol 131:138–143. https://doi.org/10.1017/S002221511600997X

    Article  CAS  PubMed  Google Scholar 

  35. Myers EN, Stangerup SE, Drozdziewicz D, Tos M, Hougaard-Jensen A (2000) Recurrence of attic cholesteatoma: different methods of estimating recurrence rates. Otolaryngol Head Neck Surg 123:283–287. https://doi.org/10.1067/mhn.2000.104666

    Article  Google Scholar 

  36. Roger G, Denoyelle F, Chauvin P, Schlegel-Stuhl N, Garabedian EN (1997) Predictive risk factors of residual cholesteatoma in children: a study of 256 cases. Am J Otol 18:550–558

    CAS  PubMed  Google Scholar 

  37. Britze A, Møller ML, Ovesen T (2017) Incidence, 10-year recidivism rate and prognostic factors for cholesteatoma. J Laryngol Otol 131:319–328. https://doi.org/10.1017/S0022215117000299

    Article  CAS  PubMed  Google Scholar 

  38. Mishra AK, Mallick A, Galagali JR, Gupta A, Sethi A, Ghotra A (2021) Mastoid cavity obliteration using bone pâté versus bioactive glass granules in the management of chronic otitis media (squamous disease): a prospective comparative study. J Laryngol Otol 135:492–500. https://doi.org/10.1017/S0022215121001195

    Article  CAS  PubMed  Google Scholar 

  39. Yung M, Tono T, Olszewska E, Yamamoto Y, Sudhoff H, Sakagami M et al (2017) EAONO/JOS joint consensus statements on the definitions, classification and staging of middle ear cholesteatoma. J Int Adv Otol 13:1–8. https://doi.org/10.5152/iao.2017.3363

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors made substantial contributions to the study conception and design. The first draft of the manuscript was written by JJL and all authors revised it critically multiple times. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Jantine J. Lindeboom.

Ethics declarations

Conflict of interest

This research received no specific grant from any funding agency, commercial or not-for-profit sectors. The authors declare that they have no conflict of interest.

Ethical approval

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional guidelines on human experimentation (both local institutions) and with the Helsinki Declaration of 1975, as revised in 2008.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lindeboom, J.J., van Kempen, P.M.W., Buwalda, J. et al. Mastoid obliteration with hydroxyapatite vs. bone pâté in mastoidectomy surgery performed on patients with cholesteatoma and chronic suppurative otitis media: a retrospective analysis. Eur Arch Otorhinolaryngol 280, 1703–1711 (2023). https://doi.org/10.1007/s00405-022-07661-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-022-07661-8

Keywords

Navigation